An emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of some cancer immunotherapies, according to a preclinical study led by Weill Cornell Medicine lymphoma researchers.
In the same way that terrestrial life evolved from ocean swimmers to land walkers, soft robots are progressing, too, thanks to recent Cornell research in battery development and design.
Weill Cornell Medicine and Weill Bugando School of Medicine collaborate to strengthen medical education, health care and innovative global health research at both institutions.
The Cornell Jeb E. Brooks School of Public Policy will host author, Cornell alumnus, and ProPublica climate reporter Abrahm Lustgarten for “On the Move: The Overheating Earth and the Uprooting of America, in the next installment of the Koen-Horowitz Lecture Series at Call Auditorium in Kennedy Hall from 7:30pm to 9:00pm on Friday, November 8.
NPR media correspondent David Folkenflik ’91 will lead a panel discussion on the role of dissenting writers in Russia, China, Belarus and elsewhere in a College of Arts and Sciences Distinguished Visiting Journalist Program event on April 17.
Jamelle Bouie, columnist for the New York Times, will be the featured speaker at the 2023 Daniel W. Kops Freedom of the Press Lecture, Sept. 12 at 5 p.m. in Klarman Hall’s Rhodes-Rawlings Auditorium.